For example, epigenetic or genetic alterations such as promoter methylation, genetic mutations, or copy number loss of NLRC5 gene can cause impaired expression or function of NLRC5, associated with reduced MHC class I expression, impaired CD8 cell recruitment, and poor survival of cancer patients52. The gene discussed is CD8A; the disease is cancer.